Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 515.55
   
  • Change Today:
    $9.80
  • 52 Week High: $544.49
  • 52 Week Low: $376.62
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,111,401
  • Market Cap: $121,665m
  • RiskGrade: 164
  • Beta: 0.01

Latest ShareCast News

US open: S&P 500, Nasdaq at record highs on strength in Morgan Stanley, Biotech

By Alexander Bueso

Date: Wednesday 19 Jul 2017

(ShareCast News) - The S&P 500 and Nasdaq Composite pushed further into record territory on the back of better-than-expected results from Morgan Stanley, with tech shares pacing the advance despite weak numbers out of Big Blue thanks to a run-up in biotech shares.

Concert Pharma shares rocket 81% higher following cystic fibrosis drug deal

By Conor Coyle

Date: Monday 06 Mar 2017

(ShareCast News) - US healthcare firm Concert Pharmaceuticals' share price shot up more than 80% on Monday after the company announced a deal to sell its cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals for $250m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 515.55
Change Today $ 9.80
% Change 1.94 %
52 Week High $544.49
52 Week Low $376.62
Volume 1,111,401
Shares Issued 235.99m
Market Cap $121,665m
Beta 0.01
RiskGrade 164

Trades for 17-Aug-2026

Time Volume / Share Price
16:00 159,485 @ $515.55
15:59 100 @ $515.57
15:59 374 @ $515.72
15:59 100 @ $515.70
15:59 100 @ $515.69

Top of Page